AstraZeneca admits in court its COVID vaccine can cause rare side effect
The pharmaceutical company has officially recognized that its covid-19 vaccine can trigger a rare blood clotting disorder in court filings in the UK.
In the early days of the covid-19 vaccine rollout there was a race to get jabs into people’s arms to slow the rapid spread of the virus. New technologies had allowed for a warp speed development of new vaccines to bring the pandemic to heal which then underwent accelerated testing regimes. They are credited with saving countless lives and suffering from the effects of covid-19.
However, a small number of reported cases of blood clots believed to be linked to the AstraZeneca shot caused several European nations to pause its use. After investigating the concerns, the European Medical Authority (EMA) came to “a clear scientific conclusion. This is a safe and effective vaccine.”
It was determined that although the EMA could not completely rule out a link between the AstraZeneca covid-19 vaccine and cases of thrombosis with thrombocytopenia syndrome, a rare blood clotting disorder, the benefits outweighed the risks associated with getting the jab. The UK drugmaker’s jabs were allowed to be used once again across the continent but doubt in their safety had been sowed among the public.
AstraZeneca admits in court its COVID vaccine can cause rare side effect
Now, the pharmaceutical company has officially acknowledged before the British courts that its vaccine against covid-19 can trigger thrombosis with thrombocytopenia syndrome (TTS) in extremely rare cases. As expected, this has quickly gone viral on social media.
The development has emerged in the context of a class action lawsuit in the United Kingdom, brought by individuals who claim to have suffered serious injuries as a result of receiving the vaccine, which was developed in collaboration with the University of Oxford.
AstraZeneca scientists previously signaled existence of rare side effect
Of course, this is not the first time that AstraZeneca has addressed the issue of possible adverse side effects of its vaccine. What’s more, in a study published in The Lancet in 2021, scientists from the company pointed out the existence of very rare cases of TTS after application.
The firm has reiterated that, despite the extremely low risk, the benefits of vaccination outweigh possible side effects, among which are included headache, fever, malaise, dizziness...
“It has also been reported that, as a rare case, an inflammation of the blood vessels in the skin could appear, which is a cutaneous vasculitis and It appears as a skin rash with red spots. This vasculitis disappears on its own, without treatment,” said Dr. Daniela Hozbord, in ‘Infobae’.
Other adverse events that may occur, according to the researcher, are inflammatory events, local pain and general discomfort due to the same inflammatory process produced by the vaccine. “These effects are treated symptomatically, i.e., the symptom is targeted, because if these effects are caused by the vaccine, they are self-limiting, unless it is something serious,” said infectiologist Ricardo Teijeiro speaking to the outlet.